Genome Surveillance, Inc.
We are developing novel Scaffold Sequencing and genome surveillance technologies for fast and accurate genome assembly, analysis and molecular diagnostics
- Stage Product In Development
- Industry Biotechnology
- Location Madison, WI, US
- Currency USD
- Founded September 2015
- Employees 2
- Incorporation Type C-corp
- Website genomesurveillance.com
Company Summary
Genome Surveillance is developing a novel “scaffold sequencing” technology to meet the growing demand of ultra long-range sequence for de novo genome sequencing, sequence finishing, genomic variation detection, haplotype-phasing, high resolution metagenomics /polyploid genomics, disease diagnosis and phenotype-genotype translation; and it is also developing a fast and cheap "genome surveillance" technology to monitor the status of human genome .
Team
Advisors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.